DOMAIN: GENOMICS & VARIANT DISCOVERY
PIPELINE #001
Germline Short-Variant Calling (WGS/WES)
Technical Scope: End-to-end discovery, joint genotyping, and functional annotation of germline SNPs and small Indels from whole-genome or whole-exome sequencing data.
Required Input Data & Formats
Paired-end FASTQ (.fastq.gz), Reference Genome (.fasta + .fai/.dict), Known Sites VCF (dbSNP, Mills Indels), Capture BED (for WES).
Produced Output Files & Deliverables
Aligned & BQSR-recalibrated CRAM/BAM (.cram/.bai), Per-sample gVCF (.g.vcf.gz), Joint-genotyped & VQSR-filtered VCF (.vcf.gz), Annotated MAF/TSV, MultiQC HTML report.
Core Software Toolchain & Frameworks
FastQC, fastp, BWA-MEM2, SAMtools, Picard MarkDuplicates, GATK4 (BaseRecalibrator, HaplotypeCaller, GenomicsDBImport, GenotypeGVCFs, VQSR), Ensembl VEP, MultiQC, nf-core/sarek.
Key Literature & Methodological References
Poplin et al. (2018) bioRxiv (GATK4); McKenna et al. (2010) Genome Research; Garcia et al. (2020) F1000Research (nf-core/sarek).
Application
When clinical accuracy and cohort scalability matter, raw sequencing reads are only as valuable as the variant calls you can trust. Our Germline Short-Variant Calling pipeline implements the gold-standard GATK4 Best Practices within a reproducible Nextflow architecture. Starting from raw FASTQ files, we automate adapter trimming, BWA-MEM2 alignment, duplicate marking, and base quality score recalibration before executing HaplotypeCaller and joint genotyping across your entire cohort. Every SNP and indel is rigorously filtered via Variant Quality Score Recalibration and enriched with clinical, population, and functional annotations through Ensembl VEP. You receive regulatory-ready, analysis-ready VCFs and comprehensive MultiQC quality dashboards—eliminating bioinformatics bottlenecks and accelerating your rare disease or population genetics discoveries from months to days.
DOMAIN: GENOMICS & VARIANT DISCOVERY
PIPELINE #002
Somatic Tumor-Normal Variant Calling & Mutational Signatures
Technical Scope: Identification of somatic SNVs, Indels, tumor mutational burden (TMB), and COSMIC mutational signatures from matched tumor-normal pairs.
Required Input Data & Formats
Tumor & Matched Normal FASTQ (.fastq.gz), Reference Genome (.fasta), Panel of Normals (PoN VCF), Germline Resource (gnomAD VCF), Target Intervals (.bed).
Produced Output Files & Deliverables
Somatic Filtered VCF (.vcf.gz), Annotated MAF (.maf), TMB & MSI Metrics (.tsv), COSMIC Mutational Signature Exposure Plots (.pdf/.png), MultiQC Report.
Core Software Toolchain & Frameworks
fastp, BWA-MEM2, GATK4 (Mutect2, GetPileupSummaries, CalculateContamination, FilterMutectCalls), Strelka2, Manta, VEP, vcf2maf, maftools, SigProfilerExtractor.
Key Literature & Methodological References
Cibulskis et al. (2013) Nature Biotechnology (Mutect); Alexandrov et al. (2020) Nature (Mutational Signatures); Mayakonda et al. (2018) Genome Research (maftools).
Application
Precision oncology demands separating true somatic driver mutations from germline background and sequencing artifacts with surgical accuracy. Our Somatic Tumor-Normal Variant Calling pipeline pairs matched tumor and normal samples through a multi-caller consensus workflow combining GATK4 Mutect2 and Strelka2. We explicitly model cross-sample contamination, orientation bias, and panel-of-normals artifacts before translating high-confidence calls into standardized MAF files. Beyond variant lists, our pipeline automatically computes Tumor Mutational Burden, Microsatellite Instability status, and decomposes COSMIC mutational signatures to reveal underlying DNA repair deficiencies or environmental exposures. Designed for translational oncology teams and clinical biomarker trials, we deliver publication-grade oncoplots and actionable variant reports ready for molecular tumor boards.
DOMAIN: GENOMICS & VARIANT DISCOVERY
PIPELINE #003
Structural Variant (SV) & Copy Number Variation (CNV) Discovery (Short-Read WGS)
Technical Scope: Detection, breakpoint refinement, and dosage genotyping of large deletions, duplications, inversions, translocations, and copy number alterations.
Required Input Data & Formats
Aligned WGS BAM/CRAM (.bam/.cram), Reference Genome (.fasta), Mappability & GC-content Tracks (.bed/.wig), Exclusion Regions BED.
Produced Output Files & Deliverables
Merged & Genotyped SV VCF (.vcf.gz), Segmented CNV Calls (.seg/.bed), Genome-wide Copy Number Profiles (.pdf), Annotated SV Table (.tsv).
Core Software Toolchain & Frameworks
Manta, Lumpy/Smoove, Delly, GRIDSS2, CNVkit, Control-FREEC, Survivor, AnnotSV, IGV-reports.
Key Literature & Methodological References
Chen et al. (2016) Bioinformatics (Manta); Jeffares et al. (2017) Nature Communications (SURVIVOR); Geoffroy et al. (2018) Bioinformatics (AnnotSV).
Application
Single-nucleotide variants tell less than half the story of genome instability and rare genetic disorders. Structural variants and copy number alterations disrupt entire genes and regulatory landscapes, yet single-tool approaches suffer from notoriously high false-positive rates. Our Short-Read SV and CNV Discovery pipeline integrates orthogonal evidence—split reads, discordant read pairs, and read-depth shifts—by combining Manta, Delly, and CNVkit, followed by consensus merging via SURVIVOR. Each structural breakpoint is annotated against gnomAD-SV, ClinGen dosage sensitivity maps, and regulatory TAD boundaries using AnnotSV. You get high-confidence, visually verifiable SV and CNV calls that uncover hidden pathogenic rearrangements and chromosomal instability missed by standard exome workflows.
DOMAIN: GENOMICS & VARIANT DISCOVERY
PIPELINE #004
Long-Read De Novo Genome Assembly & Polishing (PacBio HiFi / ONT)
Technical Scope: Chromosome-scale, haplotype-resolved de novo genome assembly, scaffolding, and quality assessment using long-read sequencing.
Required Input Data & Formats
PacBio HiFi (.bam/.fastq.gz) or Oxford Nanopore Ultra-Long Reads (.fastq.gz), Optional Hi-C Reads (.fastq.gz) for scaffolding.
Produced Output Files & Deliverables
Primary & Alternate/Haplotype-Resolved Contig/Scaffold Assemblies (.fasta), Assembly Graph (.gfa), BUSCO Completeness & QV Score Reports (.txt/.pdf).
Core Software Toolchain & Frameworks
filtlong, hifiasm, Flye, YaHS (Hi-C scaffolding), Medaka, Racon, QUAST, BUSCO, Merqury, Inspector.
Key Literature & Methodological References
Cheng et al. (2021) Nature Methods (hifiasm); Kolmogorov et al. (2019) Nature Biotechnology (Flye); Rhie et al. (2020) Genome Biology (Merqury).
Application
Reference genomes are foundational assets, and fragmented draft assemblies severely limit downstream comparative and functional genomics. Our Long-Read De Novo Genome Assembly pipeline harnesses PacBio HiFi and Oxford Nanopore ultra-long reads—optionally integrated with Hi-C chromatin conformation data—to construct contiguous, haplotype-resolved, chromosome-scale genomes. Utilizing hifiasm and Flye alongside YaHS scaffolding, we resolve complex repetitive regions, centromeres, and segmental duplications that defeat short-read assemblers. Every assembly undergoes rigorous k-mer consensus quality validation with Merqury and evolutionary gene-space benchmarking with BUSCO. Whether you are building a reference for a non-model organism, agricultural cultivar, or microbial strain, we deliver gold-standard assemblies ready for annotation and pangenomics.
DOMAIN: GENOMICS & VARIANT DISCOVERY
PIPELINE #005
Long-Read Somatic & Germline Structural Variant & Methylation Calling
Technical Scope: Simultaneous phasing of SNVs, complex structural variants, repeat expansions, and native 5mC/5hmC DNA methylation from long reads.
Required Input Data & Formats
Basecalled Long Reads with Modification Tags (unaligned BAM/POD5/FASTQ), Reference Genome (.fasta), Tandem Repeat Catalog (.bed).
Produced Output Files & Deliverables
Phased Aligned BAM (.bam), Phased Small Variant VCF (.vcf.gz), Structural Variant VCF (.vcf.gz), Repeat Expansion Genotypes (.vcf), Genome-wide 5mC BedMethyl (.bed.gz).
Core Software Toolchain & Frameworks
Dorado, minimap2, Clair3, DeepVariant, Sniffles2, CuteSV, WhatsHap, TRGT (Tandem Repeat Genotyping Tool), modkit.
Key Literature & Methodological References
Smolka et al. (2024) Nature Biotechnology (Sniffles2); Zheng et al. (2022) Nature Biotechnology (Clair3); Dolzhenko et al. (2024) Nature Biotechnology (TRGT).
Application
Long-read sequencing unlocks the dark regions of the human genome—resolving complex structural rearrangements, pathogenic tandem repeat expansions, and native epigenetic methylation in a single assay. Our Long-Read Variant and Methylation pipeline aligns PacBio HiFi or Oxford Nanopore reads with minimap2, calls high-accuracy SNVs via Clair3 or DeepVariant, and phases haplotypes directly across multi-kilobase blocks using WhatsHap. Simultaneously, Sniffles2 and TRGT resolve complex nested SVs and repeat expansions, while modkit extracts native 5mC DNA methylation profiles without bisulfite conversion. Ideal for unsolved rare disease cases and complex structural oncology, this all-in-one workflow replaces multiple legacy assays with a single, deeply informative genomic readout.
DOMAIN: GENOMICS & VARIANT DISCOVERY
PIPELINE #006
Pangenome Graph Construction & Graph-Based Genotyping
Technical Scope: Construction of variation-aware pangenome graphs from multiple assemblies and reference-bias-free read mapping and genotyping.
Required Input Data & Formats
Multiple Haplotype Assemblies (.fasta), Reference Backbone (.fasta), Cohort Short or Long Sequencing Reads (.fastq.gz).
Produced Output Files & Deliverables
Pangenome Graph (.gfa / .gbz / .xg), Graph-Aligned Read Mappings (.gam / .gaf), Pangenome Variant Calls (.vcf.gz), Core vs. Dispensable Genome Metrics.
Core Software Toolchain & Frameworks
Minigraph-Cactus, PGGB (Pangenome Graph Builder), vg (Giraffe, Call, Pack), Panacus, Bandage, odgi.
Key Literature & Methodological References
Hickey et al. (2024) Nature Biotechnology (Minigraph-Cactus); Garrison et al. (2024) Nature Methods (PGGB); Sirén et al. (2021) Science (vg Giraffe).
Application
Relying on a single linear reference genome introduces systematic allelic bias, blinding researchers to structural diversity and population-specific sequences. Our Pangenome Graph Construction and Genotyping pipeline transitions your genomics program into the graph era. Using Minigraph-Cactus or PGGB, we integrate multiple de novo assemblies into a unified, variation-aware pangenome graph that captures core and accessory sequences across strains or populations. We then map cohort sequencing reads directly onto the graph using vg Giraffe to genotype both small variants and complex structural alleles with dramatically reduced reference bias. From crop breeding programs to human population cohorts, we unlock genomic variation that linear pipelines simply cannot see.
DOMAIN: GENOMICS & VARIANT DISCOVERY
PIPELINE #007
Genome-Wide Association Study (GWAS) & Polygenic Risk Score (PRS) Pipeline
Technical Scope: Large-scale genotype quality control, imputation, mixed-model association testing, fine-mapping, and polygenic risk score calculation.
Required Input Data & Formats
Genotype Array Data (PLINK .bed/.bim/.fam or VCF), Phenotype & Covariate Tables (.tsv), Reference Imputation Panel (TOPMed/1000G).
Produced Output Files & Deliverables
QC-Filtered & Imputed Genotypes (.bgen/.vcf.gz), GWAS Summary Statistics (.tsv), Manhattan & QQ Plots (.png/.pdf), Fine-Mapped Credible Sets, Individual PRS Scores (.tsv).
Core Software Toolchain & Frameworks
PLINK2, BCFtools, Minimac4/Beagle5, REGENIE, SAIGE, GCTA-COJO, SUSIE, PRSice-2, LDpred2.
Key Literature & Methodological References
Mbatchou et al. (2021) Nature Genetics (REGENIE); Chang et al. (2015) GigaScience (PLINK2); Privé et al. (2020) Bioinformatics (LDpred2).
Application
Turning biobank-scale genotype data into actionable genetic targets requires stringent control over population stratification, cryptic relatedness, and case-control imbalance. Our end-to-end GWAS and Polygenic Risk Score pipeline automates sample and variant quality control in PLINK2, performs haplotype phasing and high-density genotype imputation, and executes whole-genome regression using REGENIE or SAIGE to handle binary and quantitative traits at scale. We follow up genome-wide significant loci with conditional analysis and statistical fine-mapping via SuSiE to pinpoint causal variants, alongside validated PRS construction using LDpred2. You receive clean summary statistics, publication-ready Manhattan plots, and calibrated risk stratification models ready for target validation or clinical stratification.
DOMAIN: GENOMICS & VARIANT DISCOVERY
PIPELINE #008
Pharmacogenomics (PGx) Star-Allele Calling & Clinical Dosing Translation
Technical Scope: Automated star-allele diplotype calling across complex pharmacogenes (e.g., CYP2D6, CYP2C19, HLA) and translation to CPIC/DPWG drug dosing guidelines.
Required Input Data & Formats
WGS/WES Aligned BAM/CRAM (.bam/.cram) or Phased VCF (.vcf.gz), Reference Genome (.fasta).
Produced Output Files & Deliverables
Star-Allele Diplotype Calls (.json/.tsv), Metabolizer Phenotype Classifications (Poor, Intermediate, Normal, Ultrarapid), CPIC Clinical Dosing Report (.pdf/.html).
Core Software Toolchain & Frameworks
PharmCAT, Aldy4, StellarPGx, Cyrius (CYP2D6), Optitype/HLA-HD, BCFtools.
Key Literature & Methodological References
Sangkuhl et al. (2020) Clinical Pharmacology & Therapeutics (PharmCAT); Hari et al. (2023) Bioinformatics (Aldy4); Chen et al. (2021) Pharmacogenomics Journal (Cyrius).
Application
Inter-individual genetic variability in drug-metabolizing enzymes drives adverse drug reactions and therapeutic failure across clinical trials and patient care. Calling pharmacogenes like CYP2D6 is notoriously difficult due to pseudogenes, structural hybrids, and copy-number variants. Our Pharmacogenomics pipeline combines specialized structural callers like Cyrius and Aldy4 with PharmCAT to accurately resolve complex star-allele diplotypes and HLA types directly from WGS or WES data. We automatically map every diplotype to metabolizer phenotypes and evidence-based CPIC and DPWG prescribing recommendations. Whether you are stratifying clinical trial responders or building precision medicine decision support, we deliver clinically interpretable PGx reports with complete auditability.
DOMAIN: GENOMICS & VARIANT DISCOVERY
PIPELINE #009
Circulating Tumor DNA (ctDNA) Liquid Biopsy & MRD Detection
Technical Scope: Ultra-sensitive UMI-aware duplex consensus calling for low-allele-frequency somatic mutations and minimal residual disease (MRD) tracking.
Required Input Data & Formats
UMI-Tagged Deep Sequencing FASTQ (.fastq.gz), Target Capture Panel BED (.bed), Reference Genome (.fasta), Optional Baseline Tumor VCF.
Produced Output Files & Deliverables
Duplex Consensus BAM (.bam), Ultra-Low VAF Variant Calls (<0.1% VAF, .vcf.gz), ctDNA Fraction & MRD Status Report (.tsv/.pdf), QC Metrics.
Core Software Toolchain & Frameworks
fgbio (ExtractUmisFromBam, GroupReadsByUmi, CallDuplexConsensusReads), BWA-MEM, VarDictJava, Mutect2, LoFreq, MultiQC.
Key Literature & Methodological References
Newman et al. (2016) Nature Biotechnology (iDES/UMI error suppression); Lai et al. (2016) Nucleic Acids Research (VarDict); Kennedy et al. (2014) Nature Protocols (Duplex Sequencing).
Application
Detecting circulating tumor DNA at variant allele frequencies below 0.1% requires separating true rare cancer molecules from PCR and sequencer noise. Our Liquid Biopsy and Minimal Residual Disease pipeline leverages Unique Molecular Identifiers (UMIs) and fgbio duplex consensus collapsing to suppress sequencing error rates by over four orders of magnitude. By collapsing read families originating from both strands of the original cfDNA molecule and applying sensitive callers like VarDictJava and LoFreq, we achieve reliable detection of sub-clonal resistance mutations and post-treatment MRD. Designed for oncology diagnostics and longitudinal clinical trial monitoring, our workflow provides quantitative ctDNA dynamics with uncompromising analytical specificity.
DOMAIN: GENOMICS & VARIANT DISCOVERY
PIPELINE #010
Telomere-to-Telomere (T2T) & Centromeric Repeat Variation Analysis
Technical Scope: Alignment, repeat array characterization, and epigenetic profiling across complete T2T-CHM13 human assemblies and acrocentric/centromeric regions.
Required Input Data & Formats
PacBio HiFi / ONT Ultra-Long Reads (.bam/.fastq.gz), T2T-CHM13v2.0 Reference (.fasta), RepeatMasker & HumAS-HMMER Annotations (.bed).
Produced Output Files & Deliverables
T2T-Aligned BAM (.bam), Alpha-Satellite Higher-Order Repeat (HOR) Profiles (.bed/.tsv), Telomere Length Distributions (.tsv/.pdf), Structural Rearrangement Calls.
Core Software Toolchain & Frameworks
Winnowmap2, minimap2, HumAS-HMMER, TeloMotif/Telogator2, Sniffles2, modkit, StainedGlass.
Key Literature & Methodological References
Nurk et al. (2022) Science (T2T-CHM13); Jain et al. (2022) Nature Methods (Winnowmap2); Altemose et al. (2022) Science (Centromere genetics/epigenetics).
Application
For two decades, centromeres, telomeres, and acrocentric short arms remained unmapped black boxes in human genetics. With the Telomere-to-Telomere CHM13 reference and long-read sequencing, these regions are now accessible and linked to chromosomal instability, aging, and neurodevelopmental disorders. Our T2T and Centromeric Variation pipeline utilizes repeat-aware aligners like Winnowmap2, specialized alpha-satellite annotation with HumAS-HMMER, and single-molecule telomere length quantification via Telogator2. We resolve higher-order repeat array architectures and centromeric methylation dips with base-pair precision. Partner with us to explore the final frontier of human genomic variation and unlock biomarkers hidden in repetitive DNA.
DOMAIN: GENOMICS & VARIANT DISCOVERY
PIPELINE #011
Mitochondrial Genome (mtDNA) Heteroplasmy & Haplogroup Analysis
Technical Scope: High-depth mitochondrial genome assembly, low-level heteroplasmy quantification, large mtDNA deletion detection, and haplogroup classification.
Required Input Data & Formats
WGS/WES or Targeted mtDNA Amplicon FASTQ/BAM (.fastq.gz/.bam), rCRS Reference Genome (.fasta), NUMT Exclusion Blacklist.
Produced Output Files & Deliverables
mtDNA Consensus FASTA (.fasta), Heteroplasmic Variant & VAF Table (.vcf.gz/.tsv), Haplogroup Assignment (.txt), Large Deletion Breakpoints (.bed).
Core Software Toolchain & Frameworks
GATK4 Mitochondria Pipeline (Mutect2 --mitochondria-mode, ShiftBack), Haplogrep3, MitoSAlt, MToolBox, SAMtools.
Key Literature & Methodological References
Laricchia et al. (2022) Genome Research (GATK mtDNA); Schönherr et al. (2023) Nucleic Acids Research (Haplogrep3); Basu et al. (2020) NAR Genomics and Bioinformatics (MitoSAlt).
Application
Analyzing mitochondrial DNA demands specialized algorithms capable of handling circular genomes, multi-copy heteroplasmy down to 1% allele frequency, and nuclear mitochondrial pseudogene (NUMT) contamination. Our Mitochondrial Genome Analysis pipeline implements the shifted-reference alignment strategy from the GATK4 Mitochondria workflow to eliminate circular breakpoint artifacts and filter out NUMT interference. We accurately quantify point heteroplasmies, detect large single or multiple mtDNA deletions via MitoSAlt, and assign high-resolution phylogenetic haplogroups using Haplogrep3. Whether investigating primary mitochondrial disorders, aging, neurodegeneration, or cancer metabolism, we provide clean, artifact-free mitochondrial genomics.
DOMAIN: GENOMICS & VARIANT DISCOVERY
PIPELINE #012
CRISPR-Cas9 / Base & Prime Editing Off-Target & On-Target Quantification
Technical Scope: Deep amplicon and genome-wide sequencing analysis to quantify NHEJ/HDR editing efficiencies, base-editing purity, and off-target cleavage.
Required Input Data & Formats
Deep Amplicon FASTQ (.fastq.gz) or GUIDE-seq/CIRCLE-seq BAM, Amplicon Reference Sequences (.fasta), sgRNA Spacer & PAM Sequences (.tsv).
Produced Output Files & Deliverables
Indel & HDR Efficiency Matrices (.tsv), Allele Frequency Frameshift & Base Substitution Plots (.pdf/.png), Genome-Wide Off-Target Ranked Table (.tsv).
Core Software Toolchain & Frameworks
CRISPResso2, Cas-OFFinder, GUIDE-seq pipeline, Flash, BWA-MEM, SAMtools, MultiQC.
Key Literature & Methodological References
Clement et al. (2019) Nature Biotechnology (CRISPResso2); Tsai et al. (2015) Nature Biotechnology (GUIDE-seq); Bae et al. (2014) Bioinformatics (Cas-OFFinder).
Application
Advancing a CRISPR, base-editing, or prime-editing therapeutic toward IND-enabling studies requires quantitative proof of on-target potency and off-target safety. Our CRISPR Editing Quantification pipeline processes deep amplicon sequencing and genome-wide unbiased cleavage assays (such as GUIDE-seq) using CRISPResso2 and custom allele-classification workflows. We precisely separate wild-type alleles, frameshift versus in-frame indels, homology-directed repair outcomes, and bystander base-editing conversions across thousands of replicates. You receive standardized, regulatory-grade editing efficiency matrices and publication-ready allele plots that de-risk your gene-editing candidates and streamline preclinical safety packages.
Back to Workflows